Citi analyst Yigal Nochomovitz raised the firm’s price target on Krystal Biotech (KRYS) to $215 from $206 and keeps a Neutral rating on the ...

EST Krystal Biotech (KRYS) sees non-GAAP R&D and SG&A expense $150.0M-$175.0M Discover the Best Stocks and Maximize Your ...

NFL offseason is officially here. Teams can start placing the franchise tag on unrestricted free agents beginning Tuesday, ...

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, and commercializes genetic medicines for patients with rare diseases in the United States. It commercializes ...

The 'Paradise' episode release schedule kicked off with a surprise early release, and now new episodes come out Tuesdays each ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

NEW ORLEANS — With Super Bowl LIX underway in Caesars Superdome, many are responding to the new score tracker on millions of ...

The screenwriter, public speaker and host of the Yearbook podcast, joins host Krys Boyd to discuss what he learned about being a Black writer for audiences hungry for stories about race and racism ...

With Super Bowl LIX underway in Caesars Superdome, many are responding to the new score tracker on millions of screens across ...

Others compared the visually appealing Super Bowl LIX logo to the decidedly more plain score bug. They spent so much energy finally spicing up the game’s logo they forgot about the scorebug ...